{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:52:00Z","timestamp":1787863920442,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-022-03218-1","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T16:02:52Z","timestamp":1668268972000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis"],"prefix":"10.1007","volume":"79","author":[{"given":"Suman","family":"Ghosal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Hadrava Vanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Uher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoli","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Meuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh-Truc","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Talvacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Knue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Prodanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A.","family":"Zeiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naris","family":"Nilubol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Crona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma T.","family":"Shankavaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"issue":"4","key":"3218_CR1","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"V. Thorsson, D.L. Gibbs, S.D. Brown et al. The Immune Landscape of Cancer. Immunity 48(4), 812\u201330.e14 (2018). https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023","journal-title":"Immunity"},{"issue":"8","key":"3218_CR2","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/onc.2009.416","volume":"29","author":"F Pages","year":"2010","unstructured":"F. Pages, J. Galon, M.C. Dieu-Nosjean, E. Tartour, C. Sautes-Fridman, W.H. Fridman, Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 29(8), 1093\u20131102 (2010). https:\/\/doi.org\/10.1038\/onc.2009.416","journal-title":"Oncogene"},{"key":"3218_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2010_46","volume":"344","author":"WH Fridman","year":"2011","unstructured":"W.H. Fridman, J. Galon, M.C. Dieu-Nosjean et al. Immune infiltration in human cancer: prognostic significance and disease control. Curr. Top. Microbiol. Immunol. 344, 1\u201324 (2011). https:\/\/doi.org\/10.1007\/82_2010_46","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"51","key":"3218_CR4","doi-asserted-by":"publisher","first-page":"18538","DOI":"10.1073\/pnas.0509182102","volume":"102","author":"E Sato","year":"2005","unstructured":"E. Sato, S.H. Olson, J. Ahn et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl Acad. Sci. USA 102(51), 18538\u201318543 (2005). https:\/\/doi.org\/10.1073\/pnas.0509182102","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"7","key":"3218_CR5","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1158\/2326-6066.CIR-18-0500","volume":"7","author":"J Cursons","year":"2019","unstructured":"J. Cursons, F. Souza-Fonseca-Guimaraes, M. Foroutan et al. A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients. Cancer Immunol. Res 7(7), 1162\u20131174 (2019). https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0500","journal-title":"Cancer Immunol. Res"},{"issue":"1","key":"3218_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40425-018-0446-3","volume":"6","author":"I Truxova","year":"2018","unstructured":"I. Truxova, L. Kasikova, M. Hensler et al. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. J. Immunother. Cancer 6(1), 139 (2018). https:\/\/doi.org\/10.1186\/s40425-018-0446-3","journal-title":"J. Immunother. Cancer"},{"issue":"24","key":"3218_CR7","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-18-1481","volume":"24","author":"MCA Wouters","year":"2018","unstructured":"M.C.A. Wouters, B.H. Nelson, Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer. Clin. Cancer Res. 24(24), 6125\u20136135 (2018). https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1481","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"3218_CR8","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1349-7006.2011.01945.x","volume":"102","author":"Y Komohara","year":"2011","unstructured":"Y. Komohara, H. Hasita, K. Ohnishi et al. Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci. 102(7), 1424\u20131431 (2011). https:\/\/doi.org\/10.1111\/j.1349-7006.2011.01945.x","journal-title":"Cancer Sci."},{"issue":"3","key":"3218_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10549-010-1154-y","volume":"128","author":"MJ Campbell","year":"2011","unstructured":"M.J. Campbell, N.Y. Tonlaar, E.R. Garwood et al. Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Res. Treat. 128(3), 703\u2013711 (2011). https:\/\/doi.org\/10.1007\/s10549-010-1154-y","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"3218_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"A.M. Newman, C.L. Liu, M.R. Green et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12(5), 453\u2013457 (2015). https:\/\/doi.org\/10.1038\/nmeth.3337","journal-title":"Nat. Methods"},{"issue":"7592","key":"3218_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"P. Bailey, D.K. Chang, K. Nones et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531(7592), 47\u201352 (2016). https:\/\/doi.org\/10.1038\/nature16965","journal-title":"Nature"},{"key":"3218_CR12","doi-asserted-by":"publisher","unstructured":"M.D. Iglesia, J.S. Parker, K.A. Hoadley, J.S. Serody, C.M. Perou, B.G. Vincent, Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types. J. Natl Cancer Inst. 108(11) (2016) https:\/\/doi.org\/10.1093\/jnci\/djw144","DOI":"10.1093\/jnci\/djw144"},{"issue":"2","key":"3218_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"L. Fishbein, I. Leshchiner, V. Walter et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell 31(2), 181\u2013193 (2017). https:\/\/doi.org\/10.1016\/j.ccell.2017.01.001","journal-title":"Cancer Cell"},{"issue":"3","key":"3218_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","volume":"57","author":"G Eisenhofer","year":"2011","unstructured":"G. Eisenhofer, J.W.M. Lenders, H. Timmers et al. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin. Chem. 57(3), 411\u2013420 (2011)","journal-title":"Clin. Chem."},{"issue":"1","key":"3218_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1677\/ERC-10-0211","volume":"18","author":"G Eisenhofer","year":"2011","unstructured":"G. Eisenhofer, K. Pacak, T.-T. Huynh et al. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr.-Relat. Cancer 18(1), 97\u2013111 (2011)","journal-title":"Endocr.-Relat. Cancer"},{"issue":"31","key":"3218_CR16","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1200\/JCO.2011.34.6353","volume":"29","author":"KS King","year":"2011","unstructured":"K.S. King, T. Prodanov, V. Kantorovich et al. Metastatic pheochromocytoma\/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J. Clin. Oncol. 29(31), 4137\u20134142 (2011). https:\/\/doi.org\/10.1200\/JCO.2011.34.6353","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"3218_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4158\/EP15725.OR","volume":"22","author":"H Turkova","year":"2016","unstructured":"H. Turkova, T. Prodanov, M. Maly et al. Characteristics and Outcomes of Metastatic Sdhb and Sporadic Pheochromocytoma\/Paraganglioma: An National Institutes of Health Study. Endocr. Pr. 22(3), 302\u2013314 (2016). https:\/\/doi.org\/10.4158\/EP15725.OR","journal-title":"Endocr. Pr."},{"issue":"34","key":"3218_CR18","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","volume":"23","author":"L Amar","year":"2005","unstructured":"L. Amar, J. Bertherat, E. Baudin et al. Genetic testing in pheochromocytoma or functional paraganglioma. J. Clin. Oncol. 23(34), 8812\u20138818 (2005). https:\/\/doi.org\/10.1200\/JCO.2005.03.1484","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"3218_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/jmedgenet-2018-105714","volume":"56","author":"L Ben Aim","year":"2019","unstructured":"L. Ben Aim, P. Pigny, L.J. Castro-Vega et al. Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma. J. Med. Genet. 56(8), 513\u2013520 (2019). https:\/\/doi.org\/10.1136\/jmedgenet-2018-105714","journal-title":"J. Med. Genet."},{"issue":"3","key":"3218_CR20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/jc.2010-1946","volume":"96","author":"M Ayala-Ramirez","year":"2011","unstructured":"M. Ayala-Ramirez, L. Feng, M.M. Johnson et al. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J. Clin. Endocrinol. Metab. 96(3), 717\u2013725 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"3218_CR21","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1530\/ERC-11-0170","volume":"18","author":"J Welander","year":"2011","unstructured":"J. Welander, P. Soderkvist, O. Gimm, Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr.-Relat. Cancer 18(6), R253\u2013R276 (2011)","journal-title":"Endocr.-Relat. Cancer"},{"issue":"11","key":"3218_CR22","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","volume":"48","author":"G Eisenhofer","year":"2012","unstructured":"G. Eisenhofer, J.W.M. Lenders, G. Siegert et al. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur. J. Cancer 48(11), 1739\u20131749 (2012)","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"3218_CR23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4158\/EP15725.OR","volume":"22","author":"H Turkova","year":"2016","unstructured":"H. Turkova, T. Prodanov, M. Maly et al. Characteristics and outcomes of metastatic sdhb and sporadic pheochromocytoma\/paraganglioma: an National Institutes of Health Study. Endocr. Pr. 22(3), 302\u2013314 (2016)","journal-title":"Endocr. Pr."},{"issue":"2","key":"3218_CR24","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1158\/1078-0432.CCR-18-0139","volume":"25","author":"S Job","year":"2019","unstructured":"S. Job, I. Draskovic, N. Burnichon et al. Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 25(2), 760\u2013770 (2019)","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"3218_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7140","volume":"6","author":"L Fishbein","year":"2015","unstructured":"L. Fishbein, S. Khare, B. Wubbenhorst et al. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nat. Commun. 6, 6140 (2015)","journal-title":"Nat. Commun."},{"issue":"2","key":"3218_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/10253890701395896","volume":"10","author":"T Zelinka","year":"2007","unstructured":"T. Zelinka, G. Eisenhofer, K. Pacak, Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice. Stress 10(2), 195\u2013203 (2007). https:\/\/doi.org\/10.1080\/10253890701395896","journal-title":"Stress"},{"issue":"5","key":"3218_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1530\/ERC-19-0024","volume":"26","author":"J Crona","year":"2019","unstructured":"J. Crona, A. Lamarca, S. Ghosal, S. Welin, B. Skogseid, K. Pacak, Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis. Endocr. Relat. Cancer 26(5), 539\u2013550 (2019). https:\/\/doi.org\/10.1530\/ERC-19-0024","journal-title":"Endocr. Relat. Cancer"},{"issue":"6","key":"3218_CR28","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1210\/jc.2018-01968","volume":"104","author":"S Hescot","year":"2019","unstructured":"S. Hescot, M. Curras-Freixes, T. Deutschbein et al. Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study. J. Clin. Endocrinol. Metab. 104(6), 2367\u20132374 (2019). https:\/\/doi.org\/10.1210\/jc.2018-01968","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3218_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/ERC-17-0306","volume":"25","author":"T Dwight","year":"2018","unstructured":"T. Dwight, A. Flynn, K. Amarasinghe et al. TERT structural rearrangements in metastatic pheochromocytomas. Endocr. Relat. Cancer 25(1), 1\u20139 (2018). https:\/\/doi.org\/10.1530\/ERC-17-0306","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"3218_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"M.D. Robinson, D.J. McCarthy, G.K. Smyth, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1), 139\u2013140 (2010). https:\/\/doi.org\/10.1093\/bioinformatics\/btp616","journal-title":"Bioinformatics"},{"issue":"7","key":"3218_CR31","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/s41588-018-0138-4","volume":"50","author":"MJ Alvarez","year":"2018","unstructured":"M.J. Alvarez, P.S. Subramaniam, L.H. Tang et al. A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors. Nat. Genet. 50(7), 979\u2013989 (2018). https:\/\/doi.org\/10.1038\/s41588-018-0138-4","journal-title":"Nat. Genet."},{"issue":"7563","key":"3218_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"J. George, J.S. Lim, S.J. Jang et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524(7563), 47\u201353 (2015). https:\/\/doi.org\/10.1038\/nature14664","journal-title":"Nature"},{"issue":"1","key":"3218_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/path.4503","volume":"236","author":"A Flynn","year":"2015","unstructured":"A. Flynn, D. Benn, R. Clifton-Bligh et al. The genomic landscape of phaeochromocytoma. J. Pathol. 236(1), 78\u201389 (2015). https:\/\/doi.org\/10.1002\/path.4503","journal-title":"J. Pathol."},{"key":"3218_CR34","doi-asserted-by":"publisher","unstructured":"N. Tufton, R.J. Hearnden, D.M. Berney, W.M. Drake, L. Parvanta, J.P. Chapple, S.A. Akker, The immune cell infiltrate in the tumour microenvironment of phaeochromocytomas and paragangliomas. Endocr. Relat. Cancer ERC-22-0020 (2022). https:\/\/doi.org\/10.1530\/ERC-22-0020","DOI":"10.1530\/ERC-22-0020"},{"issue":"7","key":"3218_CR35","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","volume":"69","author":"H Harlin","year":"2009","unstructured":"H. Harlin, Y. Meng, A.C. Peterson et al. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res. 69(7), 3077\u20133085 (2009). https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2281","journal-title":"Cancer Res."},{"issue":"3","key":"3218_CR36","doi-asserted-by":"publisher","first-page":"e1393598","DOI":"10.1080\/2162402X.2017.1393598","volume":"7","author":"F Allen","year":"2018","unstructured":"F. Allen, I.D. Bobanga, P. Rauhe et al. CCL3 augments tumor rejection and enhances CD8(+) T cell infiltration through NK and CD103(+) dendritic cell recruitment via IFNgamma. Oncoimmunology 7(3), e1393598 (2018). https:\/\/doi.org\/10.1080\/2162402X.2017.1393598","journal-title":"Oncoimmunology"},{"issue":"7","key":"3218_CR37","doi-asserted-by":"publisher","first-page":"9976","DOI":"10.18632\/aging.202754","volume":"13","author":"CX Chen","year":"2021","unstructured":"C.X. Chen, D.N. Chen, X.L. Sun et al. Identification of vital prognostic genes related to tumor microenvironment in pheochromocytoma and paraganglioma based on weighted gene co-expression network analysis. Aging (Albany NY) 13(7), 9976\u20139990 (2021). https:\/\/doi.org\/10.18632\/aging.202754","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"3218_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66449-0","volume":"10","author":"S Kim","year":"2020","unstructured":"S. Kim, A. Kim, J.Y. Shin et al. The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types. Sci. Rep. 10(1), 9536 (2020). https:\/\/doi.org\/10.1038\/s41598-020-66449-0","journal-title":"Sci. Rep."},{"issue":"2","key":"3218_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.4287","volume":"232","author":"J Galon","year":"2014","unstructured":"J. Galon, B. Mlecnik, G. Bindea et al. Towards the introduction of the \u2018Immunoscore\u2019 in the classification of malignant tumours. J. Pathol. 232(2), 199\u2013209 (2014)","journal-title":"J. Pathol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03218-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03218-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03218-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T16:21:29Z","timestamp":1715271689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03218-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["3218"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03218-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"J.C. received lecture honoraria from Novartis and participated in studies within the Knowledge Network and NETConnect initiatives that were funded by Ipsen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}